luzindole has been researched along with ibotenic acid in 2 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (ibotenic acid) | Trials (ibotenic acid) | Recent Studies (post-2010) (ibotenic acid) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 2,108 | 1 | 211 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bac, P; Evrard, P; Gressens, P; Husson, I; Mesplès, B; Vamecq, J | 1 |
| Gressens, P; Husson, I; Mocaer, E; Sarkozy, G; Schwendimann, L; Spedding, M; Vamecq, J | 1 |
2 other study(ies) available for luzindole and ibotenic acid
| Article | Year |
|---|---|
Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge.
Topics: Animals; Animals, Newborn; Antioxidants; Cell Death; Cerebral Palsy; Cystine; Denervation; Disease Models, Animal; Excitatory Amino Acid Agonists; Free Radical Scavengers; Humans; Hypothermia, Induced; Ibotenic Acid; Infant, Newborn; Leukomalacia, Periventricular; Melatonin; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neocortex; Neuroprotective Agents; Neurotoxins; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; RNA, Messenger; Tetrahydronaphthalenes; Tryptamines | 2002 |
Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity.
Topics: Acetamides; Animals; Brain; Brain Diseases; Excitatory Amino Acid Agonists; Ibotenic Acid; Melatonin; Mice; Neuroprotective Agents; Receptor, Serotonin, 5-HT2C; Receptors, Melatonin; Serotonin Antagonists; Tryptamines | 2008 |